RAFFA WEALTH MANAGEMENT, LLC’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$687 Hold
25
﹤0.01% 1124
2026
Q1
$671 Hold
25
﹤0.01% 1028
2025
Q4
$770 Hold
25
﹤0.01% 981
2025
Q3
$767 Hold
25
﹤0.01% 959
2025
Q2
$517 Sell
25
-58
-70% -$1.19K ﹤0.01% 991
2025
Q1
$1.63K Hold
83
﹤0.01% 689
2024
Q4
$1.73K Buy
83
+58
+232% +$1.27K ﹤0.01% 707
2024
Q3
$610 Hold
25
﹤0.01% 956
2024
Q2
$628 Hold
25
﹤0.01% 1010
2024
Q1
$748 Hold
25
﹤0.01% 965
2023
Q4
$796 Hold
25
﹤0.01% 881
2023
Q3
$882 Hold
25
﹤0.01% 818
2023
Q2
$950 Hold
25
﹤0.01% 812
2023
Q1
$944 Hold
25
﹤0.01% 808
2022
Q4
$1.06K Sell
25
-104
-81% -$4.29K ﹤0.01% 763
2022
Q3
$4.14K Buy
129
+64
+98% +$2.25K ﹤0.01% 423
2022
Q2
$2.11K Buy
65
+21
+48% +$680 ﹤0.01% 589
2022
Q1
$1.59K Sell
44
-29
-40% -$995 ﹤0.01% 707
2021
Q4
$2.89K Sell
73
-23
-24% -$959 ﹤0.01% 560
2021
Q3
$4.2K Hold
96
﹤0.01% 413
2021
Q2
$3.92K Buy
96
+26
+37% +$1K ﹤0.01% 438
2021
Q1
$2.3K Buy
70
+22
+46% +$827 ﹤0.01% 596
2020
Q4
$1.95K Buy
48
+27
+129% +$1.01K ﹤0.01% 562
2020
Q3
$769 Buy
21
+1
+5% +$36 ﹤0.01% 734
2020
Q2
$678 Hold
20
﹤0.01% 749
2020
Q1
$424 Buy
+20
New +$446 ﹤0.01% 775

Other funds holding GMAB

RAFFA WEALTH MANAGEMENT, LLC's GMAB Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC held its Genmab (GMAB) position steady in Q2 2026 at 25 shares worth $687. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in GMAB in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.2K in Q3 2021. 72 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 25 shares of Genmab worth $687 as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1124 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Genmab in Q1 2020 and has held it in 26 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Genmab position peaked at $4.2K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.